Long-term data from the SEQUEL extension study followed Qsymia participants for an additional year, demonstrating maintained weight loss of 9.3% at 108 weeks
Teenagers (ages 13 to 18) received less than 0.5% of prescriptions written for the top four GLP-1 drugs to patients without diabetes between 2018 and May 2023
T at Better Me Med Spa
In drug-specific analyses, exenatide was associated with reductions in ALT (Class IV
While most patients tolerate weight loss shot Mounjaro well, some may experience side effects during the early stages, including mild nausea, diarrhoea, reduced appetite, fatigue, or occasional body aches
A randomized, double-blind, placebo-controlled phase 2 trial in Denmark involving 64 adults at high fracture risk found that once-weekly subcutaneous semaglutide did not increase the bone formation marker P-PINP relative to placebo, but did increase bone resorption and led to reductions in lumbar spine and hip BMD, tibial cortical thickness, and body weight over 52 weeks [104]